Among all major cancers, pancreatic cancer has the highest rate of death – 93 percent of patients die within five years of diagnosis.
A revolutionary new treatment that harnesses the body’s own immune cells to fight tumors will be offered at the Stephenson Cancer Center at OU Medicine, beginning June 13.
John P. Zubialde, M.D., named executive dean of the University of Oklahoma College of Medicine.